Cord Blood Nesfatin-1 and Irisin in the Intrauterine Growth Restricted Fetuses
The Association of Cord Blood Nesfatin-1 and Irisin Level With Fetal Doppler Parameters in Pregnancies Complicated With Intrauterine Growth Restricted Fetuses
Sponsor: Yuzuncu Yil University
Listed as NCT03808571, this observational or N/A phase trial focuses on Intrauterine Growth Restriction and Irisin and remains completed. Sponsored by Yuzuncu Yil University, it has been updated 8 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Dec 2025 — Present [monthly]
Completed
-
Sep 2025 — Dec 2025 [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
▶ Show 3 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Feb 2019 — Nov 2020 [monthly]
Completed
First recorded
Jan 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Yuzuncu Yil University
For direct contact, visit the study record on ClinicalTrials.gov .